Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 6, 2013, Pages 441-446

  Nestvold, Torunn Kristin ^a,b   Nielsen, Erik Waage ^a,b,c   Lappegård, Knut Tore ^a,b  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORD UNIVERSITY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84888036496     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0085     Document Type: Article

References (31)

1. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: Review with metaanalysis of clinical studies. J Am Coll Nutr. 2003;22:331-339.
2. Mingrone G, Panunzi S, De GA, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-1585.
3. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243-2251.
4. Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2010;2:47-55.
5. Hofso D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2011;164:231-238.
6. Ochner CN, Kwok Y, Conceicao E, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 2011;253:502-507.
7. Park CW, Torquati A. Physiology of weight loss surgery. Surg Clin North Am 2011;91:1149-1161, vii.
8. Shamseddeen H, Getty JZ, Hamdallah IN, et al. Epidemiology and economic impact of obesity and type 2 diabetes. Surg Clin North Am 2011;91:1163-1172, vii.
9. Withrow D, Alter DA. The economic burden of obesity worldwide: A systematic review of the direct costs of obesity. Obes Rev 2011;12:131-141.
10. Hofso D, Jenssen T, Hager H, et al. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg 2010;20:302-307.
11. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
12. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis 2005;1:371-381.
13. Saaristo TE, Barengo NC, Korpi-Hyovalti E, et al. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health 2008;8:423.
14. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
15. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
16. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 2009;32:1327-1334.
17. Diagnosis and classification of diabetes mellitus Diabetes Care. 2012;35(Suppl 1):S64-S71.
18. Hofso D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010;163:735-745.
19. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008;299:316-323.
20. Jorgensen NB, Jacobsen SH, Dirksen C, et al. Acute and longterm effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012;303:E122-E131.
21. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-563.
22. Vazquez G, Duval S, Jacobs DR, Jr., et al. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: A meta-analysis. Epidemiol Rev 2007;29:115-128.
23. Wei M, Gaskill SP, Haffner SM, et al. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 1997;5:16-23.
24. Han TS, van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. Br Med J 1995;311:1401-1405.
25. Wahrenberg H, Hertel K, Leijonhufvud BM, et al. Use of waist circumference to predict insulin resistance: Retrospective study. Br Med J 2005;330:1363-1364.
26. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. Br Med J 1995;311:158-161.
27. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 2010;11:11-18.
28. Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 2010;59:3049-3057.
29. Vrieze A, Van NE, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-916.
30. Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2012;151:587-593.
31. Troseid M, Nestvold T, Rudi K, et al. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity. Diabetes Care online before print July 8, 2013, doi: 10.2337/dc13-0451.